Your browser doesn't support javascript.
loading
CXCL8 is a prognostic biomarker and correlated with TNBC brain metastasis and immune infiltration.
Shen, Yunzhu; Zhang, Baoguo; Wei, Xiaowei; Guan, Xiaoxiang; Zhang, Wenwen.
Affiliation
  • Shen Y; Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Zhang B; Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Wei X; Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Electronic address: gswxw@njmu.edu.cn.
  • Guan X; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, China. Electronic address: xguan
  • Zhang W; Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Electronic address: wwzhang1022@hotmail.com.
Int Immunopharmacol ; 103: 108454, 2022 Feb.
Article in En | MEDLINE | ID: mdl-34929481
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Brain Neoplasms / Triple Negative Breast Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Int Immunopharmacol Journal subject: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Year: 2022 Type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Brain Neoplasms / Triple Negative Breast Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Int Immunopharmacol Journal subject: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Year: 2022 Type: Article Affiliation country: China